Back to Search
Start Over
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience
- Publication Year :
- 2019
- Publisher :
- Blackwell Publishing Ltd, 2019.
- Subjects :
- Adult
Male
medicine.medical_specialty
Injections, Subcutaneous
Treatment outcome
MEDLINE
Dermatology
Antibodies, Monoclonal, Humanized
Drug Substitution
Drug Administration Schedule
Psoriasis
medicine
Humans
Settore MED/35 - Malattie Cutanee e Veneree
dermatologic agents
business.industry
Interleukin-17
Middle Aged
medicine.disease
Ixekizumab
Treatment Outcome
Multicenter study
Monoclonal
Female
Secukinumab
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....40936b9987e915614144ce80555bd3bb